Do Patients Use a Headline Section in a Leaflet to Find Key Information About Their Medicines? Findings From a User-Test Study.
In: Therapeutic Innovation & Regulatory Science, Jg. 50 (2016-09-01), Heft 5, S. 581-591
Online
academicJournal
Zugriff:
Background: In the European Union (EU), all medicines are mandated to be provided with a patient information leaflet (PIL). Many patients express concerns about the length and complexity of some PILs, and this can be a disincentive for patients to read the PILS. In order to address this, the UK’s regulatory body (Medicine and Healthcare products Regulatory Agency [MHRA]) suggested leaflets might include a headline section—information presented prominently at the beginning of a leaflet that summarizes key safety messages about a drug. Objective: To explore the extent to which readers used a headline section in a PIL, using a form of diagnostic testing called user-testing, which examines how readers find and understand key information. Methods: The study used a cross-sectional design to user-test a PIL with a headline section in a target sample of 20 participants. Participants were provided with an exemplar PIL, and the performance of the PIL was evaluated by a questionnaire and semistructured interview. Results: The results showed that a headline section was used just over one-third of the time (39%); 90% of participants used the headline section to find information when they initially began the user-test. The qualitative findings suggested that the participants valued the presence of the headline section. Conclusion: The research suggests there does not appear to be any negative impact from including a headline section in a PIL, and it is a technique that is highly valued by the consumers of medicines information. [ABSTRACT FROM AUTHOR]
Copyright of Therapeutic Innovation & Regulatory Science is the property of Springer Nature and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Titel: |
Do Patients Use a Headline Section in a Leaflet to Find Key Information About Their Medicines? Findings From a User-Test Study.
|
---|---|
Autor/in / Beteiligte Person: | Dickinson, Rebecca ; Raynor, David K. ; Knapp, Peter ; MacDonald, Jan |
Link: | |
Zeitschrift: | Therapeutic Innovation & Regulatory Science, Jg. 50 (2016-09-01), Heft 5, S. 581-591 |
Veröffentlichung: | 2016 |
Medientyp: | academicJournal |
ISSN: | 2168-4790 (print) |
DOI: | 10.1177/2168479016639080 |
Schlagwort: |
|
Sonstiges: |
|